Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine
Marc S. Lener, Mark J. Niciu, Elizabeth D. Ballard, et al.
Biological Psychiatry (2016) Vol. 81, Iss. 10, pp. 886-897
Open Access | Times Cited: 405

Showing 1-25 of 405 citing articles:

Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments
Ronald S. Duman, Gerard Sanacora, John H. Krystal
Neuron (2019) Vol. 102, Iss. 1, pp. 75-90
Open Access | Times Cited: 769
Neuroinflammation and depression: A review
Romain Troubat, Pascal Barone, Samuel Leman, et al.
European Journal of Neuroscience (2020) Vol. 53, Iss. 1, pp. 151-171
Closed Access | Times Cited: 731
Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Acute Pain Management From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists
Eric S. Schwenk, Eugene R. Viscusi, Asokumar Buvanendran, et al.
Regional Anesthesia & Pain Medicine (2018), pp. 1-1
Open Access | Times Cited: 487
Recognizing Depression from the Microbiota–Gut–Brain Axis
Shan Liang, Xiaoli Wu, Xu Hu, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 6, pp. 1592-1592
Open Access | Times Cited: 324
Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies
Sho Moriguchi, Akihiro Takamiya, Yoshihiro Noda, et al.
Molecular Psychiatry (2018) Vol. 24, Iss. 7, pp. 952-964
Open Access | Times Cited: 285
Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists
Steven P. Cohen, Anuj Bhatia, Asokumar Buvanendran, et al.
Regional Anesthesia & Pain Medicine (2018), pp. 1-1
Open Access | Times Cited: 264
Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications
Zezhi Li, Meihua Ruan, Jun Chen, et al.
Neuroscience Bulletin (2021) Vol. 37, Iss. 6, pp. 863-880
Open Access | Times Cited: 242
Kynurenine pathway in depression: A systematic review and meta-analysis
Kamiyu Ogyu, Kaoruhiko Kubo, Yoshihiro Noda, et al.
Neuroscience & Biobehavioral Reviews (2018) Vol. 90, pp. 16-25
Closed Access | Times Cited: 241
Biological hypotheses and biomarkers of bipolar disorder
Ekaterina Sigitova, Zdeněk Fišar, Jana Hroudová, et al.
Psychiatry and Clinical Neurosciences (2016) Vol. 71, Iss. 2, pp. 77-103
Open Access | Times Cited: 210
<p>Ketamine and depression: a narrative review</p>
Alexandrine Corriger, Gisèle Pickering
Drug Design Development and Therapy (2019) Vol. Volume 13, pp. 3051-3067
Open Access | Times Cited: 183
The human hypothalamus in mood disorders: The HPA axis in the center
Ai‐Min Bao, Dick F. Swaab
IBRO Reports (2018) Vol. 6, pp. 45-53
Open Access | Times Cited: 172
Differences in excitatory and inhibitory neurotransmitter levels between depressed patients and healthy controls: A systematic review and meta-analysis
Kate Godfrey, Abby C. Gardner, Sarah Kwon, et al.
Journal of Psychiatric Research (2018) Vol. 105, pp. 33-44
Closed Access | Times Cited: 166
Ketamine: A tale of two enantiomers
Luke A. Jelen, Allan H. Young, James Stone
Journal of Psychopharmacology (2020) Vol. 35, Iss. 2, pp. 109-123
Open Access | Times Cited: 162
Prefrontal excitatory/inhibitory balance in stress and emotional disorders: Evidence for over-inhibition
Chloe E. Page, Laurence Coutellier
Neuroscience & Biobehavioral Reviews (2019) Vol. 105, pp. 39-51
Open Access | Times Cited: 158
Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies
Thu Ha Pham, Alain M. Gardier
Pharmacology & Therapeutics (2019) Vol. 199, pp. 58-90
Open Access | Times Cited: 154
Convergent molecular, cellular, and cortical neuroimaging signatures of major depressive disorder
Kevin Anderson, Meghan A. Collins, Ru Kong, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 40, pp. 25138-25149
Open Access | Times Cited: 141
Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status
Ioline D. Henter, Lawrence T. Park, Carlos A. Zarate
CNS Drugs (2021) Vol. 35, Iss. 5, pp. 527-543
Open Access | Times Cited: 108
Ketamine treatment for depression: a review
Mani Yavi, Holim Lee, Ioline D. Henter, et al.
Discover Mental Health (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 82
Charting the Landscape of Genetic Overlap Between Mental Disorders and Related Traits Beyond Genetic Correlation
Guy Hindley, Oleksandr Frei, Alexey Shadrin, et al.
American Journal of Psychiatry (2022) Vol. 179, Iss. 11, pp. 833-843
Open Access | Times Cited: 69
Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder
Andrew J. Cutler, Gregory W. Mattingly, Vladimir Maletic
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 56
Janus microparticles-based targeted and spatially-controlled piezoelectric neural stimulation via low-intensity focused ultrasound
Mertcan Han, Erdost Yıldız, Ugur Bozuyuk, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 16
Glutamate-Mediated Excitotoxicity in the Pathogenesis and Treatment of Neurodevelopmental and Adult Mental Disorders
Noemi Nicosia, M. Giovenzana, Paulina Misztak, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6521-6521
Open Access | Times Cited: 16
Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
Bashkim Kadriu, Laura Musazzi, Ioline D. Henter, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 22, Iss. 2, pp. 119-135
Open Access | Times Cited: 143
Glutamatergic Dysfunction and Glutamatergic Compounds for Major Psychiatric Disorders: Evidence From Clinical Neuroimaging Studies
Cheng‐Ta Li, Kai‐Chun Yang, Wei‐Chen Lin
Frontiers in Psychiatry (2019) Vol. 9
Open Access | Times Cited: 139
Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications
Ebrahim Haroon, Andrew H. Miller
Current topics in behavioral neurosciences (2016), pp. 173-198
Closed Access | Times Cited: 129
Page 1 - Next Page

Scroll to top